Estradiol Plus Olaparib for Breast Cancer (PHOEBE)

Clinical trial NCT05900895 · RECRUITING

Trial details

NCT number: NCT05900895
Sponsor: Mary D Chamberlin
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2024-07-15
Primary completion: 2027-12-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.